Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Campesterol is a phytosterol, a plant-derived sterol structurally similar to cholesterol, found naturally in many foods including vegetable oils, nuts, and seeds. It lowers LDL cholesterol by inhibiting intestinal absorption of dietary cholesterol and exhibits anticarcinogenic properties, notably inducing apoptotic cell death in cancer cell models (e.g., ovarian, liver, and lung cancer) via mitochondrial pathways involving ROS production and caspase activation[1][6]. It also possesses anti-inflammatory effects and has been investigated for support in conditions like osteoarthritis and certain prostate disorders[6]. Campesterol is a precursor in the biosynthesis of steroid hormones and may be used as a dietary supplement to help manage cholesterol levels[5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on campesterol.